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Background: Headache disorders cause substantial productivity losses through absenteeism and impaired
effectiveness at work (presenteeism). We measured productivity losses from both causes at a heavy-manufacturing
company with a largely male workforce in north-western Turkey.
Methods: We used the HALT Index as the survey instrument. We first assessed productivity losses by surveying the
entire workforce. Because we anticipated much non-participation, we also applied HALT at the annual health-
checks provided to all employees by the company’s on-site health clinic.
Results: Mean age of the workforce (N = 7,200) was 31 yr. About two thirds (90% male) were manual workers
rotating weekly through early, late and night shifts. One third (50% male) were clerical/managerial, working a
standard 5-day week. In the first assessment, 3,939 questionnaires (54.7%) were returned with usable data. In the
previous 3 months, absenteeism of ≥1 day was reported by 360 respondents (9.1%), of whom 4 (0.10%) recorded
≥45 days (average per worker: 0.92 days/yr). Presenteeism equivalent to ≥1 day’s absence was reported by 1,187
respondents (29.4%) (average per worker: 6.0 days/yr). We estimated that 23,519 days/yr were lost in total among
respondents (2.3% of workforce capacity). In the first 6 months of annual health-checks, 2,691 employees (37.4%)
attended (94.4% male). Absenteeism was reported by 40 (1.5%), with 74 days lost, presenteeism by 348 (12.9%), with
1,240 days lost. We estimated that, altogether, 41,771 man-days/yr were lost in the entire workforce (2.4% of
capacity; 94% due to presenteeism), closely matching the earlier estimate. A small minority (5.7%) of those with
headache, who were only 2.5% of the workforce, accounted for >45% of presenteeism-related lost productivity.
Conclusion: The high productivity losses in a largely male workforce were surprising. Possible factors were the
nature of the work – manual labour for two thirds, often heavy – and the recurring schedule disturbances of shift-
work. There was a highly-disabled minority.
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Headache disorders are common, affecting men, women
and children in all parts of the world [1-4]. In Turkey, a
recent nationwide survey found that almost 50% of the
adult population had an active headache disorder and
3% were affected by headache on ≥15 days/month [5].
Headache disorders, especially migraine, impose symp-
tom burden and disability. They lead to substantial de-
mand for health care, which is poorly met [3]. They are
most troublesome during the productive years of adult-
hood. In a United Kingdom survey [6], the reported loss
of work-time due to migraine alone was 5.7 days per* Correspondence: macitselekler@hotmail.com
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in any medium, provided the original work is pyear per person affected, considerably skewed towards a
very disabled small minority. From this it can be inferred
that, in a mixed male/female workforce of 10,000 in the
UK, of whom 15% are expected to have migraine, over
30 employees will be absent every working day. This es-
timate takes no account of reduced effectiveness in those
at work despite being in a migraine attack (presentee-
ism). Neither does it include losses attributable to other
headache disorders than migraine, among which those
characterized by headache on ≥15 days/month are of
considerable importance in this regard. These other dis-
orders may, between them, multiply the losses two- or
threefold, so that headache continuously reduces work-
force capacity by >1%. The recent Eurolight project, aan open access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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Union, estimated societal losses attributable to all head-
ache disorders (direct and indirect costs) at well over
€100 billion per year [7], with more than 90% attribut-
able to lost productivity. The findings indicated a work-
force capacity reduction of at least 0.7% attributable to
all headache disorders. Importantly, this estimate was
discounted by 72%, the proportion who asserted that
they could, and generally did, “make up” time later. It is
questionable how reliable or realistic such assertions are,
and in a manufacturing industry there may be no oppor-
tunity for restitution in this way. Furthermore, when an
employee is a team member or, worse, a team leader, a
whole group may become dysfunctional through the un-
expected absence of that one person. Because of these
factors, and also because conservative assumptions were
built into the analytical model of Eurolight [7], a more
correct estimate of workforce capacity reduction may be
two or three times higher (ie, 1-2%), in line with the UK
estimate [6].
Productivity losses from headache disorders are sub-
ject not only to their prevalence but also to culture, em-
ployment levels and, in individual cases, the nature of
the particular job. Extrapolation from these findings to
Turkey, and to specific employment settings within
Turkey, may not be reliable. It is likely, nonetheless, that
losses of considerable magnitude exist. In preparation
for an interventional study to establish whether product-
ive time losses would be recoverable through the
provision of effective health care for headache (a project
within the Global Campaign against Headache [8,9]), we
undertook a study of headache-attributed time loss in
the workforce of Ford Otomotiv Sanayi AŞ (FO), a ve-
hicle manufacturing company in north-western Turkey.
At its manufacturing site in Gölcük, FO has a work-
force of 7,200 employees. Their mean age is 31 years.
Approximately two thirds (of whom 90% are male) are
manual workers who rotate weekly through early, late
and night shifts, each of 8 hours. One-third (50% male)
are clerical or managerial, working a standard 5-
day week, 8 am to 6 pm.
Ford Otosan maintains sickness-absence records for
its employees, which do not, however, include reasons
for absence. The company provides an on-site health
clinic at each site, staffed inter alia by primary health-
care physicians and nurses and providing care of day-to-
day ailments. As a service to its employees, these clinics
also carry out and record annual health-checks. These
are offered, on a rotating basis to about 10% of the
workforce each month.
Few of those with headache would be already receiving
effective care, because headache services are not well
established in primary care in Turkey. Although excel-
lent care is available nearby from the University ofKocaeli, this is a tertiary-care facility to which only lim-
ited numbers have access (about 60 new headache
patients are seen per month from the local population of
1.5 million, representing <0.25% of predicted need).
Methods
Ethics
Since this was the necessary first step in a project aimed
specifically at service improvement, it fell outside the
scope of research ethics review. While it involved the
scrutiny of company medical records, this was done only
by clinical staff directly involved in the employees’ med-
ical care. It also involved, within the company, access to
absenteeism records held legitimately by the employer.
Data-protection legislation was complied with. No per-
sonal information derived for the project passed beyond
the confines of the health clinic without first being made
anonymous.
Lost productivity assessment
We used the HALT Index [10], translated into Turkish
language, as the survey instrument. This instrument, a
close derivative of the MIDAS questionnaire [11],
discovers the existence of headache as a health problem
in the respondent through enquiry into headache-
attributed lost time. The first two questions ask about
absenteeism due to headache and reduced productivity
whilst at work with headache. To estimate total product-
ive time lost per employee, we added days wholly lost
through absenteeism and days of <50% productivity
(presenteeism). We ignored headache-affected days in
which productivity remained >50% by way of counter-
balance. This is the principle behind the MIDAS ques-
tionnaire [11].
For the individual patient in a therapeutic encounter,
the HALT Index, like MIDAS [11], counts days affected
by headache in the previous 3 months (HALT-90). This
is a compromise: it balances the need to reflect the ill-
ness over time in an individual against the considerable
problems of recall bias. In a population measure using a
large sample, there is no need to reflect the states of in-
dividuals, and therefore HALT can be applied, more reli-
ably, over a shorter time of 1 month (HALT-30).
We made an initial assessment of productivity losses
by surveying the entire workforce at Gölcük (N = 7,200).
This survey invited anonymous returns so that em-
ployees might perceive no threat from the enquiry.
HALT-90 was distributed to team leaders of every sec-
tion of the factory, who, in turn, handed the question-
naires to all employees working with them. After
completion, the questionnaires were returned via the
team leaders to the on-site health clinic.
Despite maintaining anonymity, we anticipated a high
level of non-participation in this survey, and were
Figure 1 Distribution of absenteeism in the preceding
3 months among the workforce sample (N = 3,939) in the
first survey.
Figure 2 Distribution of presenteeism in the preceding
3 months among the workforce sample (N = 3,939) in the
first survey.
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menced a more direct assessment. Over 6 months,
HALT-30 was given to every employee during his or her
annual health-check, along with the clinic’s own mate-
rials related to the health-check. These forms, completed
prior to the health-check, were collected by the super-
vising physician. As this enquiry was in the context of
individual health care, responses could be coupled with
health records held by the medical staff. They could also
be coupled with health and sickness-related absenteeism
records, but we did not do this.
Data entry and management
Questionnaires from the first survey, on its completion,
were divided between three health technicians, who
transferred the data to Excel sheets. In the second sur-
vey, questionnaires were collected day by day during the
annual health-checks and data transferred to Excel by
one health technician. Subsequently, all Excel sheets
were converted to SPSS (Statistical Package for Social
Sciences for Windows version 15.0).
Statistics
We used SPSS for descriptive statistical analyses, calcu-
lating (as appropriate) mean, standard deviation (SD),
median and inter-quartile range (IQR).
Results
Of 7,200 questionnaires distributed in the first assess-
ment, 4,033 were returned, 3,939 (54.7%) with usable
data. Because the biases introduced by self-selecting par-
ticipation in this survey were uncertain, we based the
following estimates on denominators both of 7,200 (the
entire workforce) and of 3,939 (the responding sample),
to yield ranges; the lower limits of these ranges were
conservative, while true estimates would fall somewhere
within the ranges.
Absenteeism of at least 1 day was reported in the pre-
vious 3 months by 360 respondents (representing 5.0-
9.1% of the workforce). Of these, four (0.06-0.10%)
reported absences of ≥45 days, providing evidence of a
highly-disabled small minority in a non-normal distribu-
tion (Figure 1). Total absenteeism for 3 months was
920 days. The mean absenteeism per person among the
360 was 2.55 ± 6.17 (median: 1; inter-quartile range:
1–2). Average absenteeism per worker in the entire
workforce (ie, including those with and without head-
ache) was 0.51-0.93 days per year.
Lost productivity through having headache while at
work (presenteeism) and equivalent to ≥1 day’s absence
in the previous 3 months was reported by 1,187 (16.5-
30.1%) of the workforce. Of these, 13 (0.18-0.33%)
reported lost productivity equivalent to absence on
≥45 days, similarly reflecting a highly-disabled minority(Figure 2). Total presenteeism for 3 months was
5,873 days. The mean presenteeism per person among
the 1,187 was 4.95 ± 9.07 (median: 2; IQR: 1–5). Average
presenteeism-related lost productivity per worker in the
entire workforce (ie, including those with and without
headache) was 3.3-6.0 days per year.
We detected overlap between the 360 reporting
absenteeism and the 1,187 reporting presenteeism, and
suspected a degree of double counting. Therefore, in a
re-analysis, rather than add the two we took only the
higher of the two reported numbers (that is, we as-
sumed, whenever absenteeism and presenteeism were
both reported, that there was always double counting
and that whichever was the higher number of days sub-
sumed the lower). On this conservative basis we esti-
mated that at least 23,492 days’ productivity was lost per
year at Gölcük (1.3-2.3% of workforce capacity, assuming
employees worked on average for 5 days per week and
48 weeks per year).
In the 6 months of annual health-checks, a total of
2,691 employees (37.4% of the workforce) attended, of
whom 2,541 (94.4%) were male and 150 (5.6%) female.
Mean age was 32.7 ± 5.4 years (range 20–55). In the
Figure 4 Distribution of presenteeism in the preceding 30 days
among the workforce sample (N = 2,691) in the second survey.
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715 respectively were seen (in the summer months, peri-
odic examinations are reduced, and the factory shuts
down during August). Of these, 1,162 people (43.2%) re-
ported headache on at least 1 day in the previous month.
Absenteeism was reported by 40 (3.4% of those report-
ing headache and 1.48% of the total sample), who
recorded 74 days lost in total, a mean per person of
1.85 ± 1.17 (median: 1; IQR: 1–2) (Figure 3).
Presenteeism equivalent to at least 1 day lost was
reported by 348 (29.9% of those reporting headache and
12.9% of the total sample), who recorded 1,256 days lost
in total (mean per person: 3.61 ± 3.51; median: 3; inter-
quartile range 1–4) (Figure 4). Lost days (per month)
were altogether 1,330, by far the greater part (94%)
attributed to presenteeism.
Since the general pattern reflected far fewer days of
absenteeism than of presenteeism, we suspected double
counting in nine questionnaires recording the same
number of days for each. We ignored presenteeism in
such cases, which was conservative. Effectively this re-
duced the number reporting presenteeism to 339 (12.6%
of the sample) and the days affected to 1,227. The re-
vised total of days lost was 1,301. The ratio of presentee-
ism to absenteeism was 16.6:1.
On the basis of the annual health-checks, we estimated
that productivity equivalent to 41,771 man-days was lost
per year at Gölcük (2.4% of workforce capacity), match-
ing the upper limit of the estimate from the first survey.
Probability of presenteeism was strongly driven by
reported headache frequency. Those with headache on
9–14 days/month (n = 39; 3.3% of those with any head-
ache) lost 248 days (20.2% of all lost days); those with
headache on ≥15 days/month (n = 27; 2.3% of those with
any headache) lost 307 days (25.0% of all lost days). In
other words, 5.7% of those with headache, who were
only 2.5% of the workforce, accounted for >45% of
presenteeism-related lost productivity.0.8
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Figure 3 Distribution of absenteeism in the preceding 30 days
among the workforce sample (N = 2,691) in the second survey.Probabilities of absenteeism and presenteeism were
not correlated: 35 people reporting absenteeism had only
23 days of presenteeism, while the remaining five re-
corded 65 days of presenteeism. Thus 87.5% of people
losing days through absenteeism contributed little to lost
days through presenteeism.
Discussion
The major strength of this study was the use of two dis-
tinct survey methods, each arriving at the same estimate.
The particular strengths of the second part of the study,
based on annual health-checks, were first that these take
place rotationally, with no selection by the employer,
and second that they are offered in a health-care con-
text, for the employees’ benefit, with very high uptake.
Both these factors went a long way to eliminating
participation bias. It was an unavoidable limitation that
employees’ reports were not objectively verifiable; in a
health-care setting there are no reasons to provide mis-
leading responses, but this does not guarantee complete
veracity. Additionally, estimates of presenteeism are in-
evitably both subjective and approximate, but use of
HALT-30 rather than HALT-90 at least was expected to
reduce recall bias, another major potential source of
error.
From the annual health-checks in 2,691 employees, we
recorded a 1-month prevalence of headache of 43.2%. It
is difficult to relate this to 1-year prevalence, although
the latter must be higher, including people experiencing
headache less than the median frequency of once a
month. The finding is certainly compatible with the
recent nationwide survey in Turkey, which recorded a
1-year prevalence of almost 50% [5]. Most of the work-
force at FO were male, who might have been expected
to have less headache than the population average, but
they were of an age (mean 32.7 years) at which headache
disorders – migraine in particular – tend to be
troublesome.
Work loss attributable to headache has three distinguish-
able components. Intermittent absence is an expected
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within limits credible to employers; and it is relatively
easy to measure. Reduced productivity whilst at work
despite headache (presenteeism) is less visible and much
more difficult to measure. Complete inability to work
gainfully is not apparent to employers, but a significant
drain on social security budgets. It is a relatively uncom-
mon consequence of headache alone; when it happens,
it is usually associated with frequently-recurring or un-
remitting intractable headache, often with co-morbidities.
This study focused on a group of people in paid employ-
ment, and addressed the first two components of work
loss.
The biases introduced by selective participation in the
first survey were uncertain, but we thought it likely that
those troubled by headache would have been among the
responders. We calculated ranges for each estimate
based on two denominators – those responding, and the
entire workforce – but, if our supposition was correct,
the lower limit of each range (higher denominator)
would better apply. In fact, for lost workforce capacity
attributable to headache, the range was 1.3-2.3% while
the corresponding estimate of 2.4% from the annual
health-checks was in very close agreement with the
upper limit. We expected the latter estimate to be more
robust, for the reasons given earlier. Three factors may
have been relevant. First, in the initial survey the sup-
position of preferential self-selection of those troubled
by headache might have been incorrect: it seemed likely,
but had no empirical basis. If, in fact, the 54.7% usable
returned questionnaires were a perfectly representative
sample, then the two surveys were in complete accord.
Second, the initial survey might well have been per-
ceived as a management-led initiative and, therefore,
with some suspicion. The expected consequence would
be under-reporting. The health-care setting of the sec-
ond survey addressed this. Third, as noted above, we re-
duced the estimate from the initial survey to eliminate
suspected double-counting, and this might have been
over-conservative. We therefore prefer the estimate
yielded by the annual health-checks. There is, perhaps, a
methodological lesson arising from this, of which future
employee surveys should take due note.
This said, the estimate is well above expectation in-
formed by studies in Europe [7], suggesting a higher
prevalence of disabling headache in Turkey than the
European average [2]. The recent survey in Turkey re-
ported a 1-year prevalence of migraine of 28.8% (definite
plus probable) [5], which clearly supports this. What is
surprising is this amount of loss in a largely male work-
force. Age (mean 32.7 years) has already been noted as a
factor; others may be the nature of the work – manual
labour for two thirds, often heavy – and, maybe more
contributory, the fact that these workers rotate weeklythrough early, late and night shifts (schedule distur-
bances have long been recognized as a potent migraine
trigger [12]).
The high presenteeism to absenteeism ratio (16.6:1)
may appear remarkable. From employee records, the
average absence rate for the entire workforce in 2010
(not attributable to any specific illness) was 4.54 days
per person, a workforce capacity reduction of 1.7%. The
importance of this finding is that presenteeism is largely
hidden to employers, who, on this evidence, are led to
believe that lost productivity from headache is unim-
portant since they see less than 6% of it. In the face of
disabling illness, many factors contribute to presentee-
ism rather than absenteeism [13]. We did not look at
these, because they were not central to our purpose of
measuring and reporting productivity impact – a major
part of the burden of headache [7,14] – as opposed to
explaining it. Future research may need to examine these
factors, and will have to do so in various settings, espe-
cially because this high ratio has not been seen in head-
ache surveys elsewhere [7,14]. We can meanwhile offer
one simple explanation, which is that the unemployment
situation in Turkey makes employees reluctant to be
absent.
An interesting finding to emerge, and perhaps related
to this, was that 87.5% of people losing days through ab-
senteeism contributed little to lost days through present-
eeism. It is worth noting that HALT does not measure
disability but behavioural response to impairment: un-
less disability is severe, absenteeism to some extent re-
flects choice. On the other hand, maybe these 35 people
were affected in a particular way, necessitating absentee-
ism. Nausea and vomiting, among the symptoms of mi-
graine, make it particularly difficult to travel to and be at
work.
A small minority (5.7%) of those with headache (2.5%
of the workforce) accounted for >45% of presenteeism-
related lost productivity. This operation of the Pareto
principle has been reported elsewhere. In the UK survey
[6], lost work-time due to migraine, averaging 5.7 days
per year per person affected, was considerably skewed
towards a very disabled small minority. In a Swedish sur-
vey, 3-4% of the population had most of the burden of
migraine [15]. Although they have not been well studied
epidemiologically, the group of disorders characterized
by headache on ≥15 days/month, which include
medication-overuse headache and are estimated to affect
3% of adults in Turkey [5], undoubtedly impose the
highest individual burden [7]. There is an important im-
plication in this for intervention: if the objective is to re-
duce lost productivity, health care would most efficiently
be aimed at the people who make up this disabled mi-
nority. This presupposes, of course, that these people are
treatable. And in pursuit of this objective, the less
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not be overlooked.
Conclusions
Estimates of productivity losses were well above expect-
ation informed by studies in Europe, particularly surpris-
ing in a largely male workforce but perhaps explicable
by a high prevalence of headache in Turkey, the nature
of the work and the schedule disturbances of shift-work.
As seen elsewhere, there was a highly-disabled minority.
Although this study did not have this primary purpose
(it was a base-line assessment prior to an interventional
study), it adds to the now incontrovertible evidence that
headache disorders are hugely costly to national econ-
omies [3,6,7,14] (Andrée C, Steiner TJ, Barré J et al.
Headache yesterday in Europe. submitted for publica-
tion). How much longer will it be before this is politic-
ally recognized [3,16,17]?
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